SYSTEMATIC FINANCIAL MANAGEMENT LP
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1085936
TEANECK, NJ
Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,608,047
+$2,183,100 QoQ
Shares Held
290,249
+13.7% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#88
of 561 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SYSTEMATIC FINANCIAL MANAGEMENT LP holds $199,582,267 across 6 Biotechnology names. BMRN ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
378,715 | $91,258,952 | |
| 2 | INVA |
Innoviva, Inc.
|
2,023,565 | $45,955,160 | |
| 3 | EXEL |
Exelixis, Inc.
|
649,980 | $35,365,411 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
290,249 | $16,608,047 | |
| 5 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
1,665,817 | $10,394,697 | |
| 6 | 667,883 | $0 |
All Filings in BMRN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,608,047 | 290,249 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $14,424,947 | 255,354 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $15,118,991 | 254,400 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $581,407 | 10,735 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||